900000000000526001: REPLACED BY association reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Association type\Historical association reference set (foundation metadata concept)\REPLACED BY association reference set (foundation metadata concept)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module

900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)

900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
REPLACED BY association reference set (foundation metadata concept)	est un(e) (attribut)	Historical association reference set (foundation metadata concept)	true	Inferred relationship	Some

Members	targetComponentId
Apraclonidine (as apraclonidine hydrochloride) 10 mg/mL eye solution	Product containing precisely apraclonidine (as apraclonidine hydrochloride) 10 milligram/1 milliliter conventional release eye drops (clinical drug)
Argatroban monohydrate 100 mg/mL solution for injection	Product containing precisely argatroban 100 milligram/1 milliliter conventional release solution for injection (clinical drug)
Product containing precisely argatroban monohydrate 250 milligram/2.5 milliliter conventional release solution for injection vial (clinical drug)	Product containing precisely argatroban 100 milligram/1 milliliter conventional release solution for injection (clinical drug)
Asparaginase (as crisantaspase) 10000 unit powder for solution for injection vial	Product containing precisely crisantaspase 10000 unit/1 vial powder for conventional release solution for injection (clinical drug)
Product containing precisely atorvastatin (as atorvastatin calcium trihydrate) 10 milligram/1 each conventional release oral tablet (clinical drug)	Atorvastatin (as atorvastatin calcium) 10 mg oral tablet
Product containing precisely atorvastatin (as atorvastatin calcium trihydrate) 20 milligram/1 each conventional release oral tablet (clinical drug)	Atorvastatin (as atorvastatin calcium) 20 mg oral tablet
Atorvastatin (as atorvastatin calcium trihydrate) 40 mg oral tablet	Atorvastatin (as atorvastatin calcium) 40 mg oral tablet
Atorvastatin (as atorvastatin calcium trihydrate) 80 mg oral tablet	Atorvastatin (as atorvastatin calcium) 80 mg oral tablet
Atorvastatin 10 mg oral tablet	Atorvastatin (as atorvastatin calcium) 10 mg oral tablet
Atorvastatin 20 mg oral tablet	Atorvastatin (as atorvastatin calcium) 20 mg oral tablet
Atorvastatin 40 mg oral tablet	Atorvastatin (as atorvastatin calcium) 40 mg oral tablet
Atorvastatin 80 mg oral tablet	Atorvastatin (as atorvastatin calcium) 80 mg oral tablet
Atosiban (as atosiban acetate) 37.5 mg/5 mL solution for infusion vial	Product containing precisely atosiban (as atosiban acetate) 7.5 milligram/1 milliliter conventional release solution for injection (clinical drug)
Atovaquone 250 mg and proguanil 100 mg oral tablet	Product containing precisely atovaquone 250 milligram and proguanil hydrochloride 100 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely atovaquone 62.5 milligram and proguanil 25 milligram/1 each conventional release oral tablet (clinical drug)	Product containing precisely atovaquone 62.5 milligram and proguanil hydrochloride 25 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely atropine 25 microgram and difenoxin hydrochloride 1 milligram/1 each conventional release oral tablet (clinical drug)	Product containing precisely atropine sulfate 25 microgram and difenoxin (as difenoxin hydrochloride) 1 milligram/1 each conventional release oral tablet (clinical drug)
Azacitidine 100 mg lyophilized powder for solution for injection vial	Product containing precisely azacitidine 100 milligram/1 vial powder for conventional release solution for injection (clinical drug)
Product containing precisely azathioprine 50 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Product containing precisely azathioprine (as azathioprine sodium) 50 milligram/1 vial powder for conventional release solution for injection (clinical drug)
Azilsartan medoxomil 40 mg oral tablet	Azilsartan medoxomil (as azilsartan medoxomil potassium) 40 mg oral tablet
Azilsartan medoxomil 80 mg oral tablet	Product containing precisely azilsartan medoxomil (as azilsartan medoxomil potassium) 80 milligram/1 each conventional release oral tablet (clinical drug)
Azithromycin (as azithromycin dihydrate) 250 mg oral capsule	Product containing precisely azithromycin 250 milligram/1 each conventional release oral tablet (clinical drug)
Azithromycin (as azithromycin dihydrate) 500 mg oral tablet	Azithromycin 500 mg oral tablet
Azithromycin (as azithromycin dihydrate) 500 mg powder for solution for injection vial	Azithromycin 500 mg powder for solution for injection vial
Product containing precisely azithromycin 10 milligram/1 milliliter conventional release eye solution (clinical drug)	Azithromycin 10 mg/mL eye drops
Azithromycin anhydrous (as azithromycin monohydrate) 10 mg/mL eye solution	Azithromycin 10 mg/mL eye drops
Azithromycin anhydrous (as azithromycin monohydrate) 20 mg/mL oral suspension	Product containing precisely azithromycin 20 milligram/1 milliliter conventional release oral suspension (clinical drug)
Azithromycin dihydrate 250 mg oral tablet	Product containing precisely azithromycin 250 milligram/1 each conventional release oral tablet (clinical drug)
Azithromycin dihydrate 500 mg oral tablet	Azithromycin 500 mg oral tablet
Azithromycin dihydrate 600 mg oral tablet	Product containing precisely azithromycin 600 milligram/1 each conventional release oral tablet (clinical drug)
Belimumab 120 mg lyophilized powder for solution for injection vial	Product containing precisely belimumab 120 milligram/1 vial powder for conventional release solution for injection (clinical drug)
Belimumab 400 mg lyophilized powder for solution for injection vial	Belimumab 400 mg powder for solution for injection vial
Product containing precisely betahistine 16 milligram/1 each conventional release oral tablet (clinical drug)	Betahistine dihydrochloride 16 mg oral tablet
Product containing precisely betahistine 8 milligram/1 each conventional release oral tablet (clinical drug)	Product containing precisely betahistine dihydrochloride 8 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely betamethasone dipropionate 640 microgram/1 gram and clotrimazole 10 milligram/1 gram conventional release cutaneous cream (clinical drug)	Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and clotrimazole 10 milligram/1 gram conventional release cutaneous cream (clinical drug)
Product containing precisely betaxolol hydrochloride 2.5 milligram/1 milliliter conventional release eye suspension (clinical drug)	Betaxolol (as betaxolol hydrochloride) 2.5 mg/mL eye drops
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug)	Bismuth biskalcitrate 140 mg and metronidazole 125 mg and tetracycline hydrochloride 125 mg oral capsule
Product containing precisely bisoprolol 10 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet (clinical drug)	Product containing precisely bisoprolol fumarate 10 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet (clinical drug)
Bisoprolol 2.5 mg and hydrochlorothiazide 6.25 mg oral tablet	Bisoprolol fumarate 2.5 mg and hydrochlorothiazide 6.25 mg oral tablet
Bisoprolol 5 mg and hydrochlorothiazide 6.25 mg oral tablet	Product containing precisely bisoprolol fumarate 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet (clinical drug)
Bosentan (as bosentan hydrochloride) 125 mg oral tablet	Bosentan 125 mg oral tablet
Bosentan (as bosentan hydrochloride) 62.5 mg oral tablet	Product containing precisely bosentan 62.5 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely bosutinib (as bosutinib monohydrate) 100 milligram/1 each conventional release oral tablet (clinical drug)	Bosutinib 100 mg oral tablet
Bosutinib (as bosutinib monohydrate) 500 mg oral tablet	Bosutinib 500 mg oral tablet
Product containing precisely bosutinib monohydrate 100 milligram/1 each conventional release oral tablet (clinical drug)	Bosutinib 100 mg oral tablet
Product containing precisely bosutinib monohydrate 500 milligram/1 each conventional release oral tablet (clinical drug)	Bosutinib 500 mg oral tablet
Product containing precisely bromfenac (as bromfenac sodium) 900 microgram/1 milliliter conventional release eye solution (clinical drug)	Product containing precisely bromfenac (as bromfenac sodium) 900 microgram/1 milliliter conventional release eye drops (clinical drug)
Bromocriptine 800 microgram oral tablet	Product containing precisely bromocriptine (as bromocriptine mesilate) 800 microgram/1 each conventional release oral tablet (clinical drug)
Budesonide 160 microgram and formoterol 4.5 microgram/actuation powder for inhalation	Budesonide 160 microgram and formoterol fumarate dihydrate 4.5 microgram/actuation powder for inhalation
Budesonide 80 microgram and formoterol 4.5 microgram/actuation powder for inhalation	Product containing precisely budesonide 80 microgram and formoterol fumarate dihydrate 4.5 microgram/1 actuation conventional release powder for inhalation (clinical drug)
Product containing precisely bupivacaine hydrochloride 312.5 milligram/250 milliliter conventional release solution for infusion bag (clinical drug)	Bupivacaine hydrochloride 1.25 mg/mL solution for injection
Buspirone 10 mg oral tablet	Buspirone hydrochloride 10 mg oral tablet
Buspirone 5 mg oral tablet	Buspirone hydrochloride 5 mg oral tablet
Product containing precisely canagliflozin (as canagliflozin hemihydrate) 100 milligram/1 each conventional release oral tablet (clinical drug)	Canagliflozin 100 mg oral tablet
Product containing precisely canakinumab 150 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug)	Canakinumab 150 mg powder for solution for injection vial
Product containing precisely carbidopa (as carbidopa monohydrate) 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely carbidopa (as carbidopa monohydrate) 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet (clinical drug)	Carbidopa anhydrous (as carbidopa) 12.5 mg and levodopa 50 mg oral tablet
Carbidopa (as carbidopa monohydrate) 25 mg and levodopa 100 mg oral tablet	Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 100 mg oral tablet
Carbidopa (as carbidopa monohydrate) 25 mg and levodopa 100 mg prolonged-release oral tablet	Carbidopa 25 mg and levodopa 100 mg prolonged-release oral tablet
Carbidopa (as carbidopa monohydrate) 25 mg and levodopa 250 mg oral tablet	Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely carbidopa (as carbidopa monohydrate) 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug)	Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug)
Carbidopa 10 mg and levodopa 100 mg oral tablet	Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)
Carbidopa 12.5 mg and levodopa 50 mg oral tablet	Carbidopa anhydrous (as carbidopa) 12.5 mg and levodopa 50 mg oral tablet
Carbidopa 25 mg and levodopa 100 mg oral tablet	Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 100 mg oral tablet
Carbidopa 25 mg and levodopa 250 mg oral tablet	Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet (clinical drug)
Carbidopa 25 mg oral tablet	Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely carbinoxamine 4 milligram/1 each conventional release oral tablet (clinical drug)	Carbinoxamine maleate 4 mg oral tablet
Product containing precisely carmellose sodium 10 milligram/1 milliliter conventional release eye solution (clinical drug)	Product containing precisely carmellose sodium 10 milligram/1 milliliter conventional release eye drops (clinical drug)
Carboxymethylcellulose sodium 5 mg/mL eye solution	Product containing precisely carmellose sodium 5 milligram/1 milliliter conventional release eye drops (clinical drug)
Product containing precisely cefaclor (as cefaclor monohydrate) 25 milligram/1 milliliter conventional release oral suspension (clinical drug)	Cefaclor 25 mg/mL oral suspension
Product containing precisely cefaclor (as cefaclor monohydrate) 250 milligram/1 each conventional release oral capsule (clinical drug)	Product containing precisely cefaclor 250 milligram/1 each conventional release oral capsule (clinical drug)
Cefaclor (as cefaclor monohydrate) 375 mg prolonged-release oral tablet	Product containing precisely cefaclor 375 milligram/1 each prolonged-release oral tablet (clinical drug)
Cefaclor (as cefaclor monohydrate) 50 mg/mL oral suspension	Cefaclor 50 mg/mL oral suspension
Cefaclor (as cefaclor monohydrate) 500 mg oral capsule	Cefaclor 500 mg oral capsule
Cefaclor anhydrous (as cefaclor) 250 mg chewable tablet	Product containing precisely cefaclor 250 milligram/1 each conventional release chewable tablet (clinical drug)
Product containing precisely cefadroxil (as cefadroxil monohydrate) 100 milligram/1 milliliter conventional release oral suspension (clinical drug)	Cefadroxil 100 mg/mL oral suspension
Cefadroxil (as cefadroxil monohydrate) 25 mg/mL oral suspension	Cefadroxil 25 mg/mL oral suspension
Product containing precisely cefadroxil (as cefadroxil monohydrate) 50 milligram/1 milliliter conventional release oral suspension (clinical drug)	Cefadroxil 50 mg/mL oral suspension
Product containing precisely cefadroxil (as cefadroxil monohydrate) 500 milligram/1 each conventional release oral capsule (clinical drug)	Product containing precisely cefadroxil 500 milligram/1 each conventional release oral capsule (clinical drug)
Product containing precisely cefalexin (as cefalexin monohydrate) 250 milligram/1 each conventional release oral capsule (clinical drug)	Cephalexin 250 mg oral capsule
Product containing precisely cefalexin (as cefalexin monohydrate) 250 milligram/1 each conventional release oral tablet (clinical drug)	Product containing precisely cefalexin 250 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely cefalexin (as cefalexin monohydrate) 500 milligram/1 each conventional release oral capsule (clinical drug)	Cephalexin 500 mg oral capsule
Cephalexin anhydrous (as cephalexin) 25 mg/mL oral solution	Cephalexin 25 mg/mL oral solution
Cephalexin hydrochloride 500 mg oral tablet	Product containing precisely cefalexin 500 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely cefalexin monohydrate 250 milligram/1 each conventional release oral capsule (clinical drug)	Cephalexin 250 mg oral capsule
Cephalexin monohydrate 250 mg oral tablet	Product containing precisely cefalexin 250 milligram/1 each conventional release oral tablet (clinical drug)
Cephalexin monohydrate 333 mg oral capsule	Cephalexin 333 mg oral capsule
Cephalexin monohydrate 500 mg oral capsule	Cephalexin 500 mg oral capsule
Cephalexin monohydrate 750 mg oral capsule	Cephalexin 750 mg oral capsule
Product containing precisely cefixime anhydrous (as cefixime) 40 milligram/1 milliliter conventional release oral suspension (clinical drug)	Cefixime 40 mg/mL oral suspension
Product containing precisely cefotaxime sodium 2 gram/1 vial powder for conventional release solution for injection (clinical drug)	Cefotaxime (as cefotaxime sodium) 2 g powder for solution for injection vial
Product containing precisely cefpodoxime 10 milligram/1 milliliter conventional release oral suspension (clinical drug)	Product containing precisely cefpodoxime (as cefpodoxime proxetil) 10 milligram/1 milliliter conventional release oral suspension (clinical drug)
Cefpodoxime 20 mg/mL oral suspension	Product containing precisely cefpodoxime (as cefpodoxime proxetil) 20 milligram/1 milliliter conventional release oral suspension (clinical drug)
Cefpodoxime proxetil 200 mg oral tablet	Cefpodoxime (as cefpodoxime proxetil) 200 mg oral tablet
ceftazidime 1 g, pour injection (poudre pour reconstitution) (médicament clinique)	Ceftazidime 1 g powder for solution for injection vial
ceftazidime 2 g, pour injection (poudre pour reconstitution) (médicament clinique)	Ceftazidime 2 g powder for solution for injection vial
ceftazidime 250 mg, flacon de poudre pour solution injectable (médicament clinique)	Ceftazidime 250 mg powder for solution for injection vial
ceftazidime 3 g, flacon de poudre pour solution injectable (médicament clinique)	Ceftazidime 3 g powder for solution for injection vial
ceftazidime 500 mg, pour injection (poudre pour reconstitution) (médicament clinique)	Ceftazidime 500 mg powder for solution for injection vial
Product containing precisely cefuroxime (as cefuroxime sodium) 1.5 gram/50 milliliter conventional release solution for infusion bag (clinical drug)	Cefuroxime (as cefuroxime sodium) 30 mg/mL solution for injection
Cefuroxime (as cefuroxime sodium) 750 mg/50 mL solution for infusion bag	Product containing precisely cefuroxime (as cefuroxime sodium) 15 milligram/1 milliliter conventional release solution for injection (clinical drug)
Cefuroxime 125 mg oral tablet	Product containing precisely cefuroxime (as cefuroxime axetil) 125 milligram/1 each conventional release oral tablet (clinical drug)

Start Previous Page 80 of 132 Next End

Reference Sets

Canada French language reference set (foundation metadata concept)

Reference set descriptor

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
900000000001156010	REPLACED BY association reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001157018	REPLACED BY association reference set	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)